MassChallenge was just named the #2 accelerator in the U.S. 🇺🇸 by @TIME and @Statista.
Even better: 85% of the score came from alumni feedback.
👀Read more: masschallenge.org/news/masschall…
Huge news from our 2011 cohort: @alkeuspharma, developing oral treatments for blinding retinal diseases, is being acquired by @TarsusRx in a deal worth up to $800M. Huge congratulations to Leonide Saad, Joshua Boger and the entire Alkeus team on an incredible milestone!
We welcomed the delegation from @Tokyo_gov and partners from @Deloitte Tohmatsu Venture Support to exchange ideas on how innovation ecosystems can better support deep tech #startups.
#DeepTech founders should look at the Deep Tech Tokyo Launchpad:
deeptech-tokyo.metro.tokyo.lg.jp
🧬Breakthrough Bio at MassChallenge is growing! We're expanding the team with 2 roles supporting our new global program connecting biotech/medtech startups with the U.S. Life Sciences ecosystem.
🔗Apply: masschallenge.org/careers#Biotech#MedTech#Hiring#BreakthroughBio
Thanks to the @BosBizJournal for highlighting the launch of Breakthrough Bio. Excited to help more biotech and medtech startups accelerate commercialization in the U.S.
MassChallenge is calling promising biotech and medtech ventures from Israel and Taiwan to join its new program focused on U.S. commercialization. bizjournals.com/boston/news/20…